Introduction
Intracellular cyclic guanosine monophosphate (cGMP) concentration is regulated through the control of guanylyl cyclase activity and the rate of degradation by cGMP-specific phosphodiesterase (PDE). Nitric oxide (NO) activates soluble guanylyl cyclase, thereby catalyzing the production of cGMP from GTP, whereas cGMPspecific PDE catalyzes the hydrolysis of cGMP to GMP ending signal transduction. 1 Several PDEs are specific for cGMP, however, PDE-5 isoenzyme seems to be the most relevant enzyme in cGMP inactivation in cells. Sildenafil citrate is a drug which is mainly used for the treatment of male erectile dysfunction. 1 Actions of sildenafil are widely mediated by NO/cGMP system. As a selective PDE-5 inhibitor, sildenafil increases intracellular cGMP and therefore, enhances the effect of NO in target tissues. 2, 3 Several direct effects of sildenafil administration on the nervous system have been reported in both humans and rodents, including antinociception. 4, 5 It has also been suggested that sildenafil may have proconvulsant activity in humans. 6 Riazi et al. also reported that sildenafil decreased the threshold for clonic seizures induced by intravenous administration of pentylenetetrazole (PTZ) and bicuculline and they suggested NO/cGMP pathway as a possible mediator. 7 It is well known that opioids have both anticonvulsant and proconvulsant effects on seizure threshold. 8, 9 Different studies reported that low doses of morphine show an anticonvulsant effect against seizures induced by GABA-transmission blockers like picrotoxin, bicuculline, PTZ, and isoniazid, whereas higher doses of this opioid-receptor agonist increase the susceptibility of animals to the same seizure models. 8, 10 Biphasic effects of morphine on chemical and electrical models of seizure are inhibited by sensitive doses of the m-opioid receptor antagonist naloxone. 11, 12 There is some evidences that NO pathways play a role in both phases of morphine-induced modulation of PTZ-induced seizures. 13 In previous reports, interaction between opioid system and NO signaling pathway in modulating PTZ-induced clonic seizures in mice has been shown. 10, 14 The aim of the present study is to evaluate the effect of opioid system on the proconvulsant consequences of sildenafil in the same model. There are several lines of evidence that opioidergic and nitrergic systems could modulate the seizure threshold. We previously have shown that sildenafil had proconvulsant effects in a model of clonic seizure induced by pentylenetetrazole (PTZ) or bicuculline. In the present study, we examined whether the opioid system participates in the action of sildenafil on the PTZ-induced clonic seizures in mice. Sildenafil (1, 5, 10 and 20 mg/kg, i.p.) significantly decreased the seizure threshold in a dose-dependent manner, whereas morphine had both anticonvulsant and proconvulsant effects at low (0.5, 1, and 3 mg/ kg, s.c.) and high (60 mg/kg, s.c.) doses. A sub-effective dose of sildenafil (5 mg/kg) combined with a dose of morphine (7.5 mg/kg) which was sub-effective for its proconvulsant effects significantly decreased the seizure threshold. Although naltrexone at 0.5 and 1 mg/kg had no effect on the seizure threshold, it significantly prevented both the proconvulsant effects of sildenafil as well as the anticonvulsant and proconvulsant effects of morphine on the PTZ-induced seizure thresholds. Our data suggested a role for opioidergic system in the proconvulsant effects of sildenafil on the PTZ-induced clonic seizures in mice. ß 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Materials and methods

Animals
Male NMRI mice, weighing 20-30 g from our center breeding facilities were used in this study. The animals were placed in a temperature-controlled (22 AE 3 8C) colony room on a 12-h light/12-h dark cycle with adequate and free access to food and water. All animals were adapted to the laboratory environment at least three days prior to the initiation of the procedure. 13:00 h with normal room light (12-h regular light/dark cycle) and temperature (22 AE 1 8C). All procedures were carried out in accordance with institutional guidelines for animal care and use. Each mouse underwent treatment once and each treatment group consisted of 8-10 animals.
Drugs
Morphine sulfate, naltrexone and PTZ were purchased from Sigma (Bristol, UK). Sildenafil citrate was a generous gift from Poursina Institute (Tehran, Iran). All drugs were dissolved in sterile physiological saline solution with appropriate concentrations that were administered in the volume of 5 ml/kg of mice body weight. PTZ was prepared in physiological saline as 1% solution for intravenous injections. In all study groups, sildenafil and naltrexone were administered intraperitoneally (i.p.) while morphine was administered subcutaneously (s.c.).
Determination of seizure threshold
Threshold of PTZ-induced seizure was assessed by inserting a 30-gauge dental needle into the tail vein of mice and infusion of PTZ (1%) with constant rate of 1 ml/min to unrestrained animals. Infusion continued until forelimb clonus accompanied by full clonus of the body. An index of seizure threshold defined as minimal dose of PTZ (mg/kg of mice weight) needed to induce clonic seizure. 15 
Experiments
In experiment 1, animals received different doses of morphine (0.25, 0.5, 1, 3, 7.5, 15, 30, and 60 mg/kg, s.c.) 60 min before PTZ. Animals in experiment 2 received different doses of sildenafil (1, 5, 10, and 20 mg/kg, i.p.) 30 min prior to the determination of the PTZinduced clonic seizure threshold. In experiment 3, two sub-effective doses of morphine (0.25 and 7.5 mg/kg) administered 30 min before a sub-effective doses of sildenafil (5 mg/kg) and 1 h before PTZ. In experiment 4, naltrexone (0.5 and 1 mg/kg, i.p.) was administered 15 min before sildenafil (10 and 20 mg/kg) and 45 min before PTZ. In experiment 5, naltrexone (0.5 and 1 mg/kg) was administered 15 min before morphine (0.5, 1, 3, and 60 mg/kg) and 75 min before PTZ. In all experiments saline control was included. Doses of applied drugs were chosen based on previous published articles. 7, 16 
Statistical analysis
Data are expressed as mean AE S.E.M. of clonic seizure threshold in each experimental group. The one-way or two-way analysis of variance (ANOVA) followed by the Student-Newman-Keuls post hoc test was used to analyze the data. P < 0.05 was considered as the significance level between the groups. and 60 mg/kg) on PTZ-induced clonic seizure threshold (F 8,65 = 40.131; P < 0.0001). Low doses of morphine (0.5, 1, and 3 mg/kg) were significantly anticonvulsant with maximum increase in the seizure threshold at 1 mg/kg (P < 0.001). Morphine at higher doses of 15 and 30 mg/kg decreased but this was not significant. Statistically significant proconvulsant effect was observed only at 60 mg/kg (P < 0.001). morphine at 7.5 mg/kg (which was sub-effective for proconvulsant effect) with same sildenafil dose significantly exerted a proconvulsant effect (F 3,30 = 4.712; P = 0.0082).
Results
Effect of different doses of morphine on clonic seizure threshold
Effect of sildenafil on clonic seizure threshold
Effect of naltrexone on anticonvulsant and proconvulsant effects of morphine
Low doses of naltrexone with no significant effect on the seizure threshold per se (0.5 or 1 mg/kg) significantly prevented both anticonvulsant and proconvulsant effects of morphine.
Effect of naltrexone on proconvulsant effect of sildenafil
The effect of different doses of naltrexone (0.5 and 1 mg/kg) on the proconvulsant effect of sildenafil is depicted in Fig. 4 (F 8,66 = 5.779; P < 0.0001). Pretreatment with naltrexone at 0.5 mg/kg inhibited the proconvulsant effect of sildenafil and this effect was significant (P < 0.01) at 20 mg/kg of sildenafil (F 4,45 = 8.133; P < 0.0001). Moreover, pretreatment with naltrexone at 1 mg/kg significantly prevented the proconvulsant effect of both 10 and 20 mg/kg of sildenafil (F 4,45 = 9.89; P < 0.0001).
Discussion
By using PTZ-induced clonic seizure threshold, which is a well documented method for evaluating the modulatory effects of different drugs in seizure susceptibility, 17 we demonstrated that sub-effective doses of morphine and sildenafil show an additive effect in decreasing the seizure thresholds. The opioid receptor antagonist naltrexone abolished the proconvulsant effect of sildenafil, suggesting a role for opioid system in modulating the proconvulsant effect of sildenafil on the PTZ-induced clonic seizure in mice. The biphasic effect of morphine and dose-dependent proconvulsant effect of sildenafil was confirmed in our first two experiments. It is well known that opioids (morphine) exert different effects on seizure threshold based on their dose and the models. 8, 18 While low doses of morphine show an anticonvulsant effect against seizure models induced by GABA-transmission blockers, PTZ, picrotoxin, bicuculline and isoniazid, 8, 19 higher doses of this opioid receptor agonist increase the susceptibility of animals to the same seizure models. 9 Endogenous opioids could protect against electroconvulsive shock-induced seizures 20 and are involved in the anticonvulsant properties of acute stress 21 . However, morphine at very high doses induces seizure by itself. 22 In the present study we consistently observed that low doses of morphine (0.5-3 mg/kg) had anticonvulsant effects on the PTZ-induced seizure threshold, whereas morphine at 60 mg/kg exerted proconvulsant effects. We also showed that both anticonvulsant and proconvulsant effects of systemic morphine on the seizure thresholds were m-opioid receptor mediated since they were reversible by the mopioid receptor antagonist naltrexone, which is in line with previous results using several m-opioid receptor antagonists such as naloxone and naltrexone. 8, 10, 23 Sildenafil is a potent, selective and reversible PDE5 24 that blocks cGMP hydrolysis, thereby enhancing the effects of NO in the target tissues such as corpus cavernosum. 25, 26 However, the extent and impact of central effects of sildenafil has not been completely elucidated. The recent clinical evidence also suggests that sildenafil may lead to tonic-clonic seizures and inducing relapse of bipolar disorder. 6, 27, 28 In animal models, there is some evidence that sildenafil could modulate the antinociception mechanistically distinct models of pain perception such as tail-flick (spinal and supra-spinal), hot plate (supra-spinal) acetic acid writhing and formalin (peripheral) tests. 4, [29] [30] [31] Moreover, some studies have demonstrated that sildenafil exerted an anxiogenic effect in the elevated plus maze test in mice alone or in combination with the NOS substrate L-arginine. 16, 32 Sildenafil was also reported to prevent the antidepressant-like effects of some drugs including lithium 33 and bupropion 34 in animal models of depression in rodents. Another study showed the proconvulsant effect of sildenafil to reverse anticonvulsive properties of diazepam in PTZ-induced clonic seizure model. 35 Regarding seizure models caused by mechanism other than GABAergic manipulations, sildenafil did not change the latency to cocaine-induced clonic seizure in mice. 36 Conversely, sildenafil increased the threshold for electroconvulsions in mice in a dose-dependent manner. It also increased the anticonvulsant activity of carbamazepine, valproic acid and topiramate in the maximal electroshock seizure test. 37 These differences in results may be due to the differences in the models of seizures used in the previous studies. In the present study, we showed that sildenafil resulted in a dose-dependent decrease in the PTZ-induced clonic seizure in mice, which is similar to our previous studies. 7, 35 The mechanism of the reported central effects of sildenafil is not well understood but there is evidence that NO/cGMP pathway may play a role in the aforementioned central effects of sildenafil. 7, 31, 32, 35 Accordingly, activation of NO overproduction by high doses of L-arginine has been shown to decrease PTZ-induced seizure threshold.
38
Our data also revealed that when low and per se non-effective dose of sildenafil (5 mg/kg) was administered together with a given dose of morphine (7.5 mg/kg), which was sub-effective for its proconvulsant effects, exerted a significant proconvulsant effects on the PTZ-induced clonic seizure in mice. This result suggests an interaction between sildenafil and opioidergic system in decreasing clonic seizure threshold in mice. Accordingly, we further showed that the opioid m-receptor antagonist naltrexone was able to prevent the proconvulsant effects of potent doses of sildenafil (10 and 20 mg/kg) on the seizure threshold, implicating a role foe opioid system in the proconvulsant effects of sildenafil. However, despite some evidences from previous studies in nociception, 30 combining sub-effective sildenafil with low dose morphine (0.25 mg/kg, sub-effective for its anticonvulsant effect) failed to reach a significant difference from controls (Fig. 3A) . This is in contrast with the results from the results from combining L-arginine with morphine. 10 This may be due to a difference in the mechanism of NO system modulation between these two agents or simply a difference not caught by our experiment. Sildenafil does not act at the level of opiate receptors, therefore the fact that naltrexone blocked the proconvulsant effects of sildenafil on the PTZ-induced seizure threshold suggests that endogenous opioids might have a significant participation in the proconvulsant effects of sildenafil. In fact, there is some evidence that activation of opioid receptors could modulate NO production, [39] [40] [41] [42] which in turn increases cGMP. As mentioned previously, this suggestion could be supported by the fact that NO and cGMP inhibitors are able to reverse either the proconvulsant or antinociceptive effects of morphine. 10, 30 When sildenafil is coadministered with morphine, it significantly prevents the cGMP degradation, leading to accumulation of cGMP and a decrease in seizure threshold. In agreement with this hypothesis, increased activity of either excitatory NMDA receptors 43 or L-arginine/NO 10 subsequent to opioid receptor activation have been proposed as probable mechanisms that mediate morphine-induced proconvulsant and anticonvulsant effects. In addition, the endogenously released NO participates in the excitatory transmission through NMDA receptors 44 and strong blockade of NO synthesis, by high doses of NOS inhibitors, has been shown to blocks the PTZ-induced seizures. 7, 10 Therefore, it could be suggested that opioid system plays a role in the proconvulsant effects of sildenafil on the clonic seizures induced by PTZ in mice. However, this general assumption awaits additional studies using a variety of seizure models in rodents or other species. The intravenous timed PTZ infusion which is used here in particular can be used for measures other than the generalized clonus threshold, such as observation of first myoclonic jerk and the tonic phase. 45 
Conclusions
In conclusion, the present study demonstrates that the widely used PDE-5 inhibitor sildenafil interacts with morphine in affecting mouse seizure susceptibility. The proconvulsant effect of sildenafil was prevented by the opioid receptor antagonist naltrexone in the absence of exogenous opioid, indicating a role for the opioidergic system in the seizure susceptibility effects of NO/ cGMP pathways modulated by sildenafil.
